Announcements
Sidley Represents Capricor Therapeutics in Common Stock Offering
October 24, 2024
Sidley represented Capricor Therapeutics, Inc. in connection with an underwritten public offering of 5,073,800 shares of its common stock, including the exercise in full of the underwriters’ option to purchase additional shares to cover overallotments, bringing the total gross proceeds to Capricor from the offering to approximately US$86.3 million. Piper Sandler & Co. and Oppenheimer & Co. Inc. acted as the joint book-running managers for the offering.
The deal team was led by Rob Carlson and included Nick DeAngelis and Nithya Swaminathan.
Contacts
Capabilities
Suggested News & Insights
Sidley Advises Bank RBK on Its Debut US$300 Million Eurobond OfferingMay 21, 2026Sidley Advises on Genting Group’s Landmark US$1.25 Billion Perpetual Securities Issuance and Concurrent US$1.5 Billion Tender OfferMay 20, 2026盛德助力驭势科技成功完成香港18C章项下上市项目May 20, 2026Sidley Advises the Joint Global Coordinators, Dealer Managers and Joint Bookrunners on QazaqGaz’s US$700 Million Bond Offering and Liability Management ExerciseMay 18, 2026盛德斩获2026年《金融时报》亚太创新律师大奖May 14, 2026Sidley Represents GFH as Anchor Investor in the US$5 Billion Dual IPO of Pershing Square Inc. and Pershing Square USAMay 13, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory